← Leaderboards
Bradford C Dickerson
Indiana University Indianapolis
$59,157,479
Attributed
$198,171,377
Total exposure
39
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $51.7M · FY2005–25$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$198,171,377 · 39
By mechanism
U01$130,662,749 · 2
R01$41,179,590 · 12
R56$8,486,686 · 2
R21$6,446,645 · 14
RF1$5,895,643 · 2
P30$2,755,509 · 2
Top collaborators
- Lisa Feldman Barrett17 shared
- Patrick L. Purdon13 shared
- Gil Dan Rabinovici11 shared
- Liana G Apostolova9 shared
- Maria C Carrillo9 shared
- Michael J Prerau8 shared
- Derek M Isaacowitz6 shared
- Sara W Lazar6 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Gil Dan Rabinovici$42,270,973
- Liana G Apostolova$29,240,655
- Maria C Carrillo$19,827,813
- Benjamin John Landis$2,087,460
- Bernardino Ghetti$18,641,814
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseMagnetic Resonance ImagingBrainDementiaCognitiveBiological MarkersNerve DegenerationNeuroimagingBaseAmyloidPositron-Emission TomographyTau ProteinsMemorySymptomsImageDiagnosisStructureLinkPathologyAtrophicFutureElderlyImpairment
Grant awards (117)
Addressing emotional distress in dyads of persons with a Young Onset Dementia (YOD) and their care-partners$3,379,666
RF1 · FY2025 · AG
Characterizing sleep brain dynamics associated with Alzheimer's disease pathology and progression in humans using EEG source localization and PET$1,637,641
R01 · FY2025 · AG
Neuroimaging Core$856,279
P30 · FY2025 · AG · contact PI
Robust detection of atrophy over short intervals in AD and FTLD$817,999
R01 · FY2025 · AG · contact PI
Influence of the Menopausal Transition and Lifetime Ovarian Exposure on Neural Metabolism, Connectivity and Pathology$808,819
R01 · FY2025 · AG
Biopsychosocial Mechanisms of Successful Aging$772,050
R01 · FY2025 · AG · contact PI
ADRC Consortium for Clarity in ADRD Research Through Imaging$29,557,545
U01 · FY2024 · AG
Characterizing sleep brain dynamics associated with Alzheimer's disease pathology and progression in humans using EEG source localization and PET$1,686,029
R01 · FY2024 · AG
Robust detection of atrophy over short intervals in AD and FTLD$834,693
R01 · FY2024 · AG · contact PI
Influence of the Menopausal Transition and Lifetime Ovarian Exposure on Neural Metabolism, Connectivity and Pathology$830,324
R01 · FY2024 · AG
Biopsychosocial Mechanisms of Successful Aging$787,806
R01 · FY2024 · AG · contact PI
Neuroimaging Core$665,401
P30 · FY2024 · AG · contact PI
Cortical hyperexcitability in FTD and ALS: Exploring physiological biomarkers$459,250
R21 · FY2024 · AG · contact PI
Neuromodulation of brain network function in preclinical and prodromal Alzheimer's Disease$210,000
R21 · FY2024 · AG
ADRC Consortium for Clarity in ADRD Research Through Imaging$30,800,018
U01 · FY2023 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)$13,904,119
U01 · FY2023 · AG
Toward Personalized Prognosis and Outcomes in Primary Progressive Aphasia$2,515,977
RF1 · FY2023 · NS · contact PI
Characterizing sleep brain dynamics associated with Alzheimer's disease pathology and progression in humans using EEG source localization and PET$1,871,738
R01 · FY2023 · AG
Robust detection of atrophy over short intervals in AD and FTLD$834,693
R01 · FY2023 · AG · contact PI
Biopsychosocial Mechanisms of Successful Aging$788,646
R01 · FY2023 · AG · contact PI
Neuromodulation of brain network function in preclinical and prodromal Alzheimer's Disease$252,000
R21 · FY2023 · AG
Imaging Core$243,022
P30 · FY2023 · AG · contact PI
Computational psycholinguistic analysis of speech samples in PPA and AD and FTD$239,265
R21 · FY2023 · DC · contact PI
Individualized Closed-Loop Neuromodulation Therapy for Alzheimer's Disease$206,449
R21 · FY2023 · AG
Biopsychosocial Mechanisms of Successful Aging$811,526
R01 · FY2022 · AG · contact PI
A video intervention to improve decision making in early-onset dementia caregivers$589,750
R01 · FY2022 · AG · contact PI
Individualized Closed-Loop Neuromodulation Therapy for Alzheimer's Disease$262,718
R21 · FY2022 · AG
Neuroimaging of the Vulnerable Brain in Delirium: Alzheimer's and Aging Imaging Markers$259,912
P01 · FY2022 · AG · contact PI
Imaging Core$243,022
P30 · FY2022 · AG · contact PI
Use of machine learning to quantify cognitive function in AD, FTD, and DLB$239,868
R21 · FY2022 · AG · contact PI
Computational psycholinguistic analysis of speech samples in PPA and AD and FTD$203,425
R21 · FY2022 · DC · contact PI
Early Onset AD Consortium - the LEAD Study (LEADS)$16,618,207
U01 · FY2021 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)$1,072,053
U01 · FY2021 · AG
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology$836,669
R01 · FY2021 · MH
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG$811,850
R01 · FY2021 · AG
The Aging Brain Under General Anesthesia: Neurophysiology, Neuroimaging Biomarkers of Aging and Alzheimer's Disease, and Post-Operative Cognitive Outcomes$631,035
R01 · FY2021 · AG
A video intervention to improve decision making in early-onset dementia caregivers$589,750
R01 · FY2021 · AG · contact PI
Muli-scale Structural Imaging of Alzheimer's Disease Neuropathology and Neurodegeneration$461,108
R21 · FY2021 · AG
Neuroimaging of the Vulnerable Brain in Delirium: Alzheimer's and Aging Imaging Markers$260,347
P01 · FY2021 · AG · contact PI
Imaging Core$248,527
P30 · FY2021 · AG · contact PI
Use of machine learning to quantify cognitive function in AD, FTD, and DLB$203,241
R21 · FY2021 · AG · contact PI
Early Onset AD Consortium - the LEAD Study (LEADS)$15,954,813
U01 · FY2020 · AG
Imaging tau, amyloid, and neurodegeneration in PPA$854,998
R01 · FY2020 · DC · contact PI
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology$850,275
R01 · FY2020 · MH
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG$826,867
R01 · FY2020 · AG
The Aging Brain Under General Anesthesia: Neurophysiology, Neuroimaging Biomarkers of Aging and Alzheimer's Disease, and Post-Operative Cognitive Outcomes$639,246
R01 · FY2020 · AG
A video intervention to improve decision making in early-onset dementia caregivers$589,750
R01 · FY2020 · AG · contact PI
Neuroimaging of the Vulnerable Brain in Delirium: Alzheimer's and Aging Imaging Markers$410,153
P01 · FY2020 · AG · contact PI
Imaging Core$256,236
P30 · FY2020 · AG · contact PI
Early Onset AD Consortium - the LEAD Study (LEADS)$11,820,016
U01 · FY2019 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)$2,473,288
U01 · FY2019 · AG
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology$861,633
R01 · FY2019 · MH
Imaging tau, amyloid, and neurodegeneration in PPA$854,998
R01 · FY2019 · DC · contact PI
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG$837,363
R01 · FY2019 · AG
Neural and cognitive changes associated with mindfulness training in older adults$713,397
R01 · FY2019 · AG
The Aging Brain Under General Anesthesia: Neurophysiology, Neuroimaging Biomarkers of Aging and Alzheimer's Disease, and Post-Operative Cognitive Outcomes$646,062
R01 · FY2019 · AG
A video intervention to improve decision making in early-onset dementia caregivers$589,750
R01 · FY2019 · AG · contact PI
Neuroimaging of the Vulnerable Brain in Delirium: Alzheimer's and Aging Imaging Markers$407,478
P01 · FY2019 · AG · contact PI
Imaging Core$243,022
P30 · FY2019 · AG · contact PI
Early Onset AD Consortium - the LEAD Study (LEADS)$176,937
U01 · FY2019 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)$8,285,753
U01 · FY2018 · AG
Imaging tau, amyloid, and neurodegeneration in PPA$854,998
R01 · FY2018 · DC · contact PI
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG$844,721
R01 · FY2018 · AG
Biopsychosocial Mechanisms of Superaging$832,369
R56 · FY2018 · AG
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology$782,548
R01 · FY2018 · MH
Neural and cognitive changes associated with mindfulness training in older adults$713,397
R01 · FY2018 · AG
The Aging Brain Under General Anesthesia: Neurophysiology, Neuroimaging Biomarkers of Aging and Alzheimer's Disease, and Post-Operative Cognitive Outcomes$653,243
R01 · FY2018 · AG
A video intervention to improve decision making in early-onset dementia caregivers$589,750
R01 · FY2018 · AG · contact PI
Neural and cognitive changes associated with mindfulness training in older adults$418,124
R01 · FY2018 · AG
Neuroimaging of the Vulnerable Brain in Delirium: Alzheimer's and Aging Imaging Markers$385,246
P01 · FY2018 · AG · contact PI
Neuromodulation of memory and language networks in Alzheimer's disease$210,625
R21 · FY2018 · AG · contact PI
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology$83,408
R01 · FY2018 · MH
Early Onset Alzheimer's Disease Consortium$7,654,317
R56 · FY2017 · AG
Imaging tau, amyloid, and neurodegeneration in PPA$854,998
R01 · FY2017 · DC · contact PI
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG$854,981
R01 · FY2017 · AG
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology$791,698
R01 · FY2017 · MH
Neural and cognitive changes associated with mindfulness training in older adults$710,364
R01 · FY2017 · AG
The Aging Brain Under General Anesthesia: Neurophysiology, Neuroimaging Biomarkers of Aging and Alzheimer's Disease, and Post-Operative Cognitive Outcomes$659,671
R01 · FY2017 · AG
Neuromodulation of memory and language networks in Alzheimer's disease$256,500
R21 · FY2017 · AG · contact PI
Tau Imaging in Atypical AD$213,750
R21 · FY2017 · AG
Core F - Neuroimaging Core$187,442
P50 · FY2017 · AG · contact PI
Imaging tau, amyloid, and neurodegeneration in PPA$854,998
R01 · FY2016 · DC · contact PI
Neural and cognitive changes associated with mindfulness training in older adults$713,399
R01 · FY2016 · AG
Neural Mechanisms of Affective Salience in Aging$660,358
R01 · FY2016 · AG
Tau Imaging in Atypical AD$256,500
R21 · FY2016 · AG
Neural Mechanisms of Affective Salience in Aging$744,719
R01 · FY2015 · AG
Neural and cognitive changes associated with mindfulness training in older adults$710,366
R01 · FY2015 · AG
Autosomal Dominant FTLD Tauopathy Patient-Specific Stem Cell Models$217,500
R21 · FY2015 · NS · contact PI
Neural Mechanisms of Affective Salience in Aging$683,985
R01 · FY2014 · AG
Autosomal Dominant FTLD Tauopathy Patient-Specific Stem Cell Models$261,000
R21 · FY2014 · NS · contact PI
Pilot study of preclinical and prodromal frontotemporal degeneration$215,325
R21 · FY2014 · NS · contact PI
Imaging biomarkers of the FTD-ALS spectrum$215,325
R21 · FY2014 · NS · contact PI
Neural Mechanisms of Affective Salience in Aging$98,077
R01 · FY2014 · AG
Neural Mechanisms of Affective Salience in Aging$45,866
R01 · FY2014 · AG
Neural Mechanisms of Affective Salience in Aging$646,233
R01 · FY2013 · AG
Imaging biomarkers of the FTD-ALS spectrum$261,000
R21 · FY2013 · NS · contact PI
Pilot study of preclinical and prodromal frontotemporal degeneration$256,560
R21 · FY2013 · NS · contact PI
Large scale language networks Topography and selective degeneration$209,888
R21 · FY2013 · NS · contact PI
Social cognitive impairment in frontotemporal degeneration and schizophrenia$208,800
R21 · FY2013 · MH · contact PI
Neural Mechanisms of Affective Salience in Aging$675,134
R01 · FY2012 · AG
Large scale language networks Topography and selective degeneration$261,375
R21 · FY2012 · NS · contact PI
Social cognitive impairment in frontotemporal degeneration and schizophrenia$261,125
R21 · FY2012 · MH · contact PI
Medial temporal lobe subregions in aging, MCI and AD:Structural and functional M$430,477
R01 · FY2011 · AG · contact PI
Medial temporal lobe subregions in aging, MCI and AD:Structural and functional M$458,335
R01 · FY2010 · AG · contact PI
Medial temporal lobe subregions in aging, MCI and AD:Structural and functional M$555,270
R01 · FY2009 · AG · contact PI
Ultrahigh-resolution in vivo and ex vivo MRI of human medial temporal lobe$187,443
R21 · FY2009 · AG · contact PI
Medial temporal lobe subregions in aging, MCI and AD:Structural and functional M$425,859
R01 · FY2008 · AG · contact PI
Ultrahigh-resolution in vivo and ex vivo MRI of human medial temporal lobe$216,605
R21 · FY2008 · AG · contact PI
Medial temporal lobe subregions in aging, MCI and AD:Structural and functional M$459,256
R01 · FY2007 · AG · contact PI
Structural-functional MRI Studies of Memory in MCI & AD$156,600
K23 · FY2007 · AG · contact PI
Structural-functional MRI Studies of Memory in MCI & AD$156,600
K23 · FY2006 · AG · contact PI
ENHANCING HUMAN CORTICAL PASTICITY: VISUAL PSYCHOPHYSICS & MRI$2,464
M01 · FY2006 · RR · contact PI
Structural-functional MRI Studies of Memory in MCI &AD$156,600
K23 · FY2005 · AG
ENHANCING HUMAN CORTICAL PASTICITY: VISUAL PSYCHOPHYSICS &MRI$18,647
M01 · FY2005 · RR
Structural-functional MRI Studies of Memory in MCI &AD$156,600
K23 · FY2004 · AG
ENHANCING HUMAN CORTICAL PLASTICITY: VISUAL PSYCHOPHYSIC$29,866
M01 · FY2004 · RR
Structural-functional MRI Studies of Memory in MCI &AD$156,600
K23 · FY2003 · AG